BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20659897)

  • 1. Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition.
    Palmieri Lde C; Lima LM; Freire JB; Bleicher L; Polikarpov I; Almeida FC; Foguel D
    J Biol Chem; 2010 Oct; 285(41):31731-41. PubMed ID: 20659897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex.
    Hyung SJ; Deroo S; Robinson CV
    ACS Chem Biol; 2010 Dec; 5(12):1137-46. PubMed ID: 20845945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
    Zanotti G; Berni R
    Vitam Horm; 2004; 69():271-95. PubMed ID: 15196886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
    Raghu P; Sivakumar B
    Biochim Biophys Acta; 2004 Dec; 1703(1):1-9. PubMed ID: 15588697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP.
    Naylor HM; Newcomer ME
    Biochemistry; 1999 Mar; 38(9):2647-53. PubMed ID: 10052934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
    Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
    J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function studies on human retinol-binding protein using site-directed mutagenesis.
    Sivaprasadarao A; Findlay JB
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):437-42. PubMed ID: 8002949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
    Castro-Rodrigues AF; Gales L; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2011 Dec; 67(Pt 12):1035-44. PubMed ID: 22120741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin.
    Noy N; Slosberg E; Scarlata S
    Biochemistry; 1992 Nov; 31(45):11118-24. PubMed ID: 1445851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6.
    Berry DC; Croniger CM; Ghyselinck NB; Noy N
    Mol Cell Biol; 2012 Oct; 32(19):3851-9. PubMed ID: 22826435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?
    Palaninathan SK
    Curr Med Chem; 2012; 19(15):2324-42. PubMed ID: 22471981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
    Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
    J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ile-84-->Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein.
    Berni R; Malpeli G; Folli C; Murrell JR; Liepnieks JJ; Benson MD
    J Biol Chem; 1994 Sep; 269(38):23395-8. PubMed ID: 8089102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition.
    Mangrolia P; Murphy RM
    Biochemistry; 2018 Aug; 57(33):5029-5040. PubMed ID: 30024734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
    Cotrina EY; Oliveira Â; Leite JP; Llop J; Gales L; Quintana J; Cardoso I; Arsequell G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.
    Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW
    Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical basis for retinol deficiency induced by the I41N and G75D mutations in human plasma retinol-binding protein.
    Folli C; Viglione S; Busconi M; Berni R
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1017-22. PubMed ID: 16157297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of retinol-binding protein-transthyretin interaction and techniques to identify competing ligands.
    Mata NL; Phan K; Han Y
    Methods Mol Biol; 2010; 652():209-27. PubMed ID: 20552431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between retinol-binding protein and transthyretin analyzed by fluorescence anisotropy.
    Folli C; Favilla R; Berni R
    Methods Mol Biol; 2010; 652():189-207. PubMed ID: 20552430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.
    Yokoyama T; Mizuguchi M
    J Med Chem; 2019 Feb; 62(4):2076-2082. PubMed ID: 30688456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.